11-Dehydro-TXB2
-
11-Dehydro-TXB2
structure -
-
CAS No:
67910-12-7
-
Formula:
C20H32O6
-
Chemical Name:
11-Dehydro-TXB2
-
Synonyms:
5-Heptenoic acid,7-[(2R,3S,4S)-tetrahydro-4-hydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]-6-oxo-2H-pyran-3-yl]-,(5Z)-;Thromboxa-5,13-dien-1-oic acid,9,15-dihydroxy-11-oxo-,(5Z,9α,13E,15S)-;5-Heptenoic acid,7-[(2R,3S,4S)-tetrahydro-4-hydroxy-2-[(1E,3S)-3-hydroxy-1-octenyl]-6-oxo-2H-pyran-3-yl]-,(5Z)-;(5Z)-7-[(2R,3S,4S)-Tetrahydro-4-hydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]-6-oxo-2H-pyran-3-yl]-5-heptenoic acid;11-Dehydrothromboxane B2;11-Dehydro-TXB2;11-keto-Thromboxane B2;5-Heptenoic acid,7-[tetrahydro-4-hydroxy-2-(3-hydroxy-1-octenyl)-6-oxo-2H-pyran-3-yl],[2R-[2α(1E,3S*),3β(Z),4β]]-
- Categories:
-
CAS No:
Description
ChEBI: A thromboxane obtained by formal oxidation of the hemiacetal hydroxy function of thromboxane B2.
11-Dehydro-TXB2 Use and Manufacturing
A metabolite of Thromboxane that is an in vivo markers of oxidative stress and platelet activation. It is associated with adverse cardiovascular events in Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
Computed Properties
Molecular Weight:368.5
XLogP3:2.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:12
Exact Mass:368.21988874
Monoisotopic Mass:368.21988874
Topological Polar Surface Area:104
Heavy Atom Count:26
Complexity:485
Undefined Atom Stereocenter Count:4
Undefined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 11-Dehydro-TXB2
-
![China]()
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Custom Synthetic Chemicals,Biological Stains,Pharmaceutical Intermediates,Cosmetic Grade Chemicals,Enzyme,Nucleosides,Indicators,Speciality Chemicals,Biological Chemicals,Enzyme Substrates
Learn More Other Chemicals
-
10-hydroxy-10-(3-octa-2,5-dienyloxiran-2-yl)deca-5,8-dienoic acid
103188-12-1
-
(5E,9E)-8-hydroxy-10-[3-[(2E,5E)-octa-2,5-dienyl]oxiran-2-yl]deca-5,9-dienoic acid
103188-13-2
-
(4-benzamidophenyl) (Z)-7-[(1R,2R,3R)-3-hydroxy-2-(2-hydroxy-3-phenoxypropoxy)-5-oxocyclopentyl]hept-4-enoate
106342-69-2
-
20-dimethyl-7-thiaprostaglandin E1 methyl ester Formula
111037-12-8
-
11-deoxyprostaglandin E1 4-hydroxyphenyl ester Formula
114495-95-3
-
16,18-ethano-20-ethyl-6-oxoprostaglandin E1 leucinamide Formula
115288-30-7
-
(5S,6Z,8E,10E,12R,14Z)-5,12-Dihydroxy-20-oxo-6,8,10,14-eicosatetraenoic acid Structure
115609-68-2
-
EP 171 Structure
115825-93-9
-
What is 5,12,19-trihydroxyicosa-6,8,10,14-tetraenoic acid
117605-61-5
-
What is (E)-7-[5-chloro-2-[(E)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid
117708-11-9